Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
BPC-157 is commonly used daily for 4-8 week cycles based on preclinical safety data showing no adverse effects at therapeutic doses
Obesity in adults
Some may qualify for another form of relief
Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) Long-acting amylin analog studied for obesity and metabolic disease
US$ 23.14
US$ 26.46
US$ 28.63
US$ 23.28
US$ 25.51
US$ 29.27
US$ 21.79
